Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-158.37M
↓ 104% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-77.64M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-158.37M | -36.0% |
| 2024 | $-116.45M | -119.6% |
| 2023 | $-53.03M | -43.8% |
| 2022 | $-36.88M | -57.3% |
| 2021 | $-23.44M | - |